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Abstract Growth factor Neuregulin 1 (NRG1) plays an
essential role in development and organization of the
cerebral cortex. NRG1 and its receptors, ERBB3 and
ERBB4, have been implicated in genetic susceptibility for
schizophrenia. Disease symptoms include asociality and
altered social interaction. To investigate the role of NRG1-
ERBB signaling in social behavior, mice heterozygous for
an Nrg1 null allele (Nrg1+/−), and mice with conditional
ablation of Erbb3 or Erbb4 in the central nervous system,
were evaluated for sociability and social novelty preference
in a three-chambered choice task. Results showed that
deficiencies in NRG1 or ERBB3 significantly enhanced
sociability. All of the mutant groups demonstrated a lack of
social novelty preference, in contrast to their respective
wild-type controls. Effects of NRG1, ERBB3, or ERBB4
deficiency on social behavior could not be attributed to
general changes in anxiety-like behavior, activity, or loss of
olfactory ability. Nrg1+/− pups did not exhibit changes in
isolation-induced ultrasonic vocalizations, a measure of
emotional reactivity. Overall, these findings provide evi-
dence that social behavior is mediated by NRG1-ERBB
signaling.
Keywords Grin1 . Growth factor . NMDA receptor .
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Introduction
Genome-wide linkage studies, case-control association
studies, and functional data have implicated Neuregulin 1
(NRG1) in the etiology of schizophrenia [18, 56, 57].
NRG1 is known to play critical roles in the development
and patterning of the cerebral cortex [1, 2, 13, 15, 35, 51,
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55]. NRG1 promotes the generation and maintenance of
cerebral cortical radial glia, and enhances the migration of
cortical neuroblasts in the embryonic cortex. NRG1-ERBB4
receptor tyrosine kinase interactions also promote neural
progenitor cell proliferation and interneuronal migration in
the adult forebrain. NRG1 can induce the expression of N-
methyl-D-aspartate receptor (NMDAR) 2C and GABA-A
ß2 subunits in cerebellar granule neurons, and the α-7
subunit of acetylcholine receptor (AchR) in hippocampal
neurons [5]. In the hippocampal CA1 region, NRG1 can
reverse or rapidly suppress the induction of long term
potentiation (LTP) [22, 28], possibly through stimulation of
dopamine release and subsequent D4 dopamine receptor
signaling [29]. Moreover, NRG1-ERBB4 interactions can
both modulate glutamate receptor activity in hippocampus
and enhance GABAergic release from interneurons in the
prefrontal cortex [32, 59]. Finally, NRG1-ERBB4 signaling
can modulate gamma oscillations in cortex, thought to be
critical for normal cognitive functions [11, 12].
Collectively, these studies suggest that defects in NRG1-
ERBB signaling could alter the generation, placement,
differentiation, or physiological function of neurons in the
developing and adult brain. Resultant changes in neural
circuitry and electrophysiology in the cerebral cortex may
thus lead to neurodevelopmental disorders such as schizo-
phrenia. In support of this hypothesis, recent studies
indicate that altered NRG1-ERBB4 interactions may en-
hance susceptibility to schizophrenia [45] and that NRG1(I)
expression is deregulated in dorsolateral prefrontal cortex
and hippocampus in schizophrenia [19, 31]. We investigat-
ed whether NRG1- and ERBB- deficient mouse models
have alterations in social approach, relevant to symptoms of
asociality and impaired social interaction in schizophrenia,
as well as autism, fragile X syndrome, and other neuro-
developmental disorders.
Mice homozygous for a targeted null allele of Nrg1
(Nrg1−/−) die during embryogenesis, but heterozygous
mice (Nrg1+/−) are viable [36]. Nrg1+/− mice have
significant decreases in Nrg1 mRNA expression as embryos
and adults, suggesting that heterozygous carriers can be
used to study disruption of NRG1-ERBB signaling postna-
tally. In particular, Nrg1+/− mice have been examined as a
possible mouse model relevant to genetic susceptibility for
schizophrenia. Several studies have found that Nrg1 mice
are hyperactive in various experimental settings [4, 14, 46,
47, 57]. However, there are conflicting results from acoustic
startle tests of sensorimotor gating, with reports of impaired
prepulse inhibition [57] and normal prepulse inhibition [4]
in Nrg1+/− mice. Similarly, both reduced [4] and un-
changed [47] anxiety-like behavior have been observed.
One study failed to find any behavioral alterations in Nrg1
+/− mice during a social interaction test [4], while others
have reported increased aggression [46, 47]. The particular
background strains used to maintain different Nrg1 mutant
lines may be a factor in the inconsistent behavioral profiles.
An additional source for inconsistencies in phenotypes
may be due to differences in how and which isoform of
Nrg1 was disrupted. Nrg1 mutant lines include those
targeting the transmembrane (TM) domain [4, 46, 47, 57]
and the immunoglobulin (Ig)-like domain [50]. The Nrg1
mutant line in the present study had targeted deletion of the
epidermal growth factor (EGF)-like domain that is common
to all isoforms [14, 36]. It is notable that, unlike other Nrg1
mutant lines, the Ig-domain Nrg1+/− mice do not show
hyperactivity [50].
In the present study, social approach behaviors were
examined in two separate cohort groups of Nrg1+/− mice
using a three-chambered choice test [39, 44]. The cohorts
were assessed for sociability, defined as a preference for
spending more time in the proximity of another mouse,
versus being alone, and for social novelty preference,
defined as preference for a novel social partner, versus an
already-investigated social partner. Furthermore, mice with
central nervous system (CNS) deletion of Erbb3 or Erbb4
were evaluated using the same test. In contrast to Nrg1+/−
mice, Erbb3+/− mice are not hyperactive in an open field
test [14]. However, Erbb4+/− mice have a mild increase in
locomotion, although there are no detectable changes in
prepulse inhibition of acoustic startle responses [57]. The
present study included Erbb3 and Erbb4 conditional mutant
lines in order to determine if changes in social behavior
observed in Nrg1+/− mice were mediated through specific
ERBB receptors.
An important issue for interpreting results from social
approach tests is that altered preference for the social
partner may reflect general changes in activity, motor or
sensory function, or anxiety, rather than selective effects on
social behavior. In the present study, information from
several control measures, including activity in an open field
and anxiety-like behavior in an elevated plus maze, was
considered in the interpretation of results from the social
choice test. These measures provided evidence for whether
changes in social approach could be attributed to overall
hyperactivity, altered anxiety, or other characteristics of the
mutant mice.
Methods
Animals
Nrg1 null mutation Wild-type (Nrg1+/+) and heterozygous
(Nrg1+/−) male mice were maintained on a B6D2F1/CrlBR
(or BDF1; Charles River) background. Two separate
cohorts of adult Nrg1 +/+ and +/− mice were evaluated.
Mice in cohort 1 were 1.5 to 3 months of age (mean age=
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2.7 months) at the beginning of testing, while mice in
cohort 2 were 2 to 5.5 months of age (mean age=
4.2 months) at the beginning of testing. In addition, a
separate set of Nrg1 +/+ and +/− mice was tested for
ultrasonic vocalizations during the neonatal period. Female
Nrg1+/+ mice were crossed with male Nrg1+/− mice to
provide litters. Day of birth was considered postnatal day
(PD) 1. Pups from 7–10 L were tested on PDs 5, 7, and 10.
Erbb3 conditional deletion Male mice with a conditional
deletion of Erbb3 (Erbb3tm2Dwt, Lee et al. submitted) were
crossed with mice carrying Nestin-Cre recombinase to
generate a CNS-specific deletion of Erbb3 (Erbb3tm2Dwt/tm2Dwt,
Nestin-Cre). Mice were on a mixed C57BL/6J×129S1/SvImJ
background. Testing began when animals were 3 to 6 months
of age (mean age was 4.6 months).
Erbb4 conditional deletion Mice in which the second exon
of the Erbb4 gene was flanked by loxP were crossed with
transgenic mice that expressed Cre recombinase under the
control of human GFAP (hGFAP) promoter to generate
mice with conditional deletion of Erbb4 in the CNS
(Erbb4lox/-hGFAP-Cre [1]). Mice were on a mixed
C57BL/6J×129S1/SvImJ background. Testing began when
mice were approximately 8 months of age.
Subject numbers for each of the adult mouse lines are
given in Table 1. Mice were housed in ventilated cages,
with free access to water and Purina 5,058 chow. The
housing room had a 12-hr light/dark cycle (lights off at
7:00 P.M.). Genotyping was conducted by PCR from tail or
toe tissue samples. All procedures were conducted in strict
compliance with the policies on animal welfare of the
National Institutes of Health and the University of North
Carolina (stated in the “Guide for the Care and Use of
Laboratory Animals,” Institute of Laboratory Animal
Resources, National Research Council, 1996 edition).
Behavioral testing
The order of testing for each adult group was: 1) elevated
plus maze; 2) neurobehavioral screen; 3) activity in an open
field; 4) rotarod; 5) social approach test; and 6) buried food
test for olfactory ability. Only one procedure was conducted
per day. Detailed descriptions of these tests have been
previously published [42]. For the neonatal assessments,
pups were tested for ultrasonic vocalizations on postnatal
days 5, 7, and 10.
Elevated plus-maze test Mice were given one 5-min trial on
the plus-maze, which had two closed arms, with walls
20 cm in height, and two open arms. The maze was
elevated 50 cm from the floor, and the arms were 30 cm
long. Animals were placed on the center section (8 cm×
8 cm), and allowed to freely explore the maze. Arm entries
were defined as all four paws entering an arm. Entries and
time in each arm were recorded during the trial by a human
Table 1 Control measures in Nrg1, Erbb3, and Erbb4 mouse lines. Data shown are means ± SEM for body weight, percent time in and percent
entries into the open arms of an elevated plus maze, total arm entries on the maze, latency to fall from a rotarod (trial 5), latency to find buried
food and percent of group finding the food in a test for olfactory ability
N Body weight (g) %Open arm Total entries Rotarod latency (s) Olfactory test
Time Entries Entries Trial 1 Trial 5 latency (s) % group
Nrg1
Cohort 1
Nrg1+/+ 10 27±1 4±1% 11±2% 16±1 141±25 260±21 396±120 70%
Nrg1+/− 10 27±1 6±2% 15±3% 19±2 103±30 230±28 205±89 90%
Cohort 2
Nrg1+/+ 16 35±1 4±1% 9±2% 12±1 236±17 300±0 316±90 75%
Nrg1+/− 15 33±1 4±1% 11±3% 12±2 207±22 295±3 75±12 * 100%
Erbb3 WT 10 33±2 2±1% 11±6% 5±2 77±11 169±17 144±85 90%
Erbb3 cKO 12 25±0* 0.5±0% 4±2% 6±1 132±14* 187±21 158±32 100%
Erbb4 WT 11a 34±4c 22±4% 25±4% 25±3 110±30 240±32 172±77 90%
Erbb4 cKO 14b 43±1*c 30±3% 29±2% 31±2 61±13 234±24 474±104* 57%
WT wild-type, cKO conditional knockout
a 3 males and 8 females
b 7 males and 7 females. All other subject numbers are for male mice
c Body weights are given for male mice
*p<0.05, comparison to wild-type group from same mouse line
easures in Nrg1, Er b3, and Er b4 mouse lines.
Data hown are means ± SEM for body weight, percent time i and
percent entries int the o en arms of an elevated plus maze, total arm
entries on the maze, latency t fall from a rotarod (trial 5), latency to
find buried food and pe cent of group finding the food in a test for
olfactory ability
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observer via computer coding. Percent open arm time was
calculated as 100 × (time spent on the open arms/(time in
the open arms + time in the closed arms)). Percent open
arm entries was calculated using the same formula.
Neurobehavioral screen Mice were evaluated for general
health, including bodyweight, appearance of fur andwhiskers,
body posture, and normality of gait. Reflexive reactions were
assessed with a gentle touch from a cotton swab to the
whiskers on each side of the face, an approach of the cotton
swab to the eyes, and the sound from a metal clicker. Animals
were also observed for the visual placing reflex (forepaw
extension when lowered toward a visible surface), and for
ability to grasp a metal grid with forepaws and hindpaws.
Open field Exploratory activity in a novel environment was
assessed for 1 h in a photocell-equipped automated open field
(40 cm×40 cm×30 cm; Versamax system, Accuscan Instru-
ments). Measures were taken of total distance traveled during
the test. Activity chambers were contained inside sound-
attenuating boxes, equipped with houselights and fans.
Rotarod performance Mice were assessed for balance and
motor coordination on an accelerating rotarod (Ugo-Basile,
Stoelting Co., Wood Dale, Il). Revolutions per minute (rpm)
were set at an initial value of 3, with a progressive increase to
a maximum of 30 rpm across the 5-min test session. Each
animal was given a test session consisting of three trials, with
45 s between each trial. Two additional trials were given 48 h
later. Latency to fall, or to rotate off the top of the turning
barrel, was measured by the rotarod timer.
Olfactory test following food deprivation Several days
before the olfactory test, an unfamiliar food (Froot Loops,
Kellogg Co., Battle Creek, MI) was placed overnight in the
home cages, in order to avoid food neophobia on the day of
testing. 16–20 h before the test, all food was removed from
the home cage. On the day of the test, each mouse was
placed in a large, clean tub cage (46 cm L×23.5 cm W×
20 cm H), containing 3 cm deep paper chip bedding
(Canbrands Product, Moncton NB, Canada), and allowed to
explore for 5 min. The animal was removed from the cage,
and 1 Froot Loop was buried in the cage bedding,
approximately 1 cm below the surface of the litter. The
subject mouse was then returned to the cage for a 15 min
test. Measures were taken of latency to find the buried food.
Sociability and preference for social novelty Mutant lines
were tested in an automated three-chambered box [39, 42,
44]. Dividing walls had retractable doorways allowing
access into each chamber. The automated box had photo-
cells embedded in each doorway to allow quantification of
entries and duration in each chamber of the social test box.
The chambers of the apparatus were cleaned with water and
dried with paper towels between each trial. At the end of
each test day, the apparatus was sprayed with 70% ethanol
and wiped clean with paper towels.
The choice test had three 10-min phases: 1) Habituation.
The test mouse was first placed in the middle chamber and
allowed to explore, with the doorways into the two side
chambers open. 2) Sociability. After the habituation period,
the test mouse was enclosed in the center compartment of
the social test box, and an unfamiliar mouse (stranger 1; an
adult C57BL/6J male) was enclosed in a wire cage (11 cm
H, 10.5 bottom diameter, Galaxy Cup, Spectrum Diversi-
fied Designs, Inc., Streetsboro, Ohio) and placed in a side
chamber. The location for stranger 1 alternated between the
left and right sides of the social test box across subjects. An
empty wire cage was placed in the opposite side chamber,
to serve as a novel object control. Following placement of
stranger 1, the doors were re-opened, and the subject was
allowed to explore the entire social test box. Measures were
taken of the amount of time spent in each chamber and the
number of entries into each chamber by the automated
testing system. 3) Preference for social novelty. At the end
of the sociability test, each mouse was further tested for
preference to spend time with a new stranger. A new
unfamiliar mouse was placed in the wire cage that had been
empty during the previous session. The test mouse then had
a choice between the first, already-investigated mouse
(stranger 1) and the novel unfamiliar mouse (stranger 2).
The same measures were taken as with the sociability test.
Ultrasonic vocalizations On PDs 5, 7, and 10, the home
cage containing the dam and litter was taken into the
laboratory. The dam was removed, and the home cage was
kept warm by placement on a heated surface (32.5°C,
hotplate apparatus, IITC Life Science, Woodland Hills,
CA). For the test, each pup was taken from the home cage
and placed into a plastic beaker. The beaker was set into a
sound-attenuating chamber (a small cooler), and ultrasonic
vocalizations were recorded for 5 min by a bat detector and
Ultravox software (Noldus Information Technology, Wage-
ningen, the Netherlands). Measures included vocalization
frequency and average duration in the 50 kHz range. Data
were also recorded at the 30, 40, and 60 kHz range from
three additional bat detectors, to insure that the optimal
sampling range was utilized. Following the first test on
PD5, one toe was removed from each pup for genotyping
and subject identification.
Statistical analysis
Data from each mutant mouse line were analyzed using 1-
way ANOVAs (analysis of variance) or repeated measures
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ANOVAs. Significant effects of altered genotype found in
the ANOVAs were further explored using post-hoc Fisher’s
PLSD (protected least-significant difference) tests. Social
preference was determined using within-genotype repeated
measures ANOVAs, with the factor of chamber side (e.g.,
stranger 1 side or the opposite side). For the ultrasonic
vocalization experiment, n = number of litters, rather than
individual pups. Analyses were conducted on the mean
wild-type and Nrg1+/− values from each litter. Because we
were not able to collect data from every litter at every time
point, separate one-way ANOVAs were conducted for each
postnatal day. For all comparisons, significance was set at
p<0.05.
Results
Control measures
Mice were evaluated for general health, sensory and motor
ability, anxiety-like behavior and activity, since impairment
in any of these domains of function could alter performance
in the three-chambered social approach test. The neuro-
behavioral screen did not reveal any overt deficits in the
mutant mouse lines. As shown in Table 1, the Nrg1 +/+ and
+/− mice of both cohort groups were similar in body
weight, anxiety-like behavior on the elevated plus maze,
and motor coordination on the rotarod. In cohort 2, the
Nrg1 mutant mice had significantly lower latencies than
wild-type mice to uncover a buried food [F(1,28)=6.1, p=
0.0199].
The Erbb3 conditional mutant group weighed signifi-
cantly less than the wild-type group at the beginning of
testing (Table 1), and at the middle and end of testing
[data not shown; post-hoc tests following significant main
effect of genotype, F(1,20)=26.05; p<0.0001]. The lower
body weight was not linked to differences in age (mean
age ± SEM at beginning of testing: Erbb3 wild-type, 4.7±
0.3 months, Erbb3 mutant, 4.5±0.3 months). In the Erbb4
groups, separate analyses for the male and female mice
revealed that mutant males had significantly higher body
weights than wild-type males at 8–9 months of age [F(1,8)=
8.1, p=0.0216]. There were no differences in body weight in
the female Erbb4 groups. The Erbb4 mutant mice had
significantly longer latencies than the wild-type controls to
uncover the buried food in the olfactory test [F(1,23)=4.95,
p=0.0362].
Previous studies have reported that Nrg1+/− mice have
enhanced performance on the rotarod [14]. While this
characteristic was not observed in either of the two Nrg1
cohorts of the present study, the Erbb3 mutant mice had
significantly longer latencies to fall than the wild-type mice
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a novel open field. Data shown
are means (± SEM) for each
group for a one-hour test ses-
sion. WT = wild-type, cKO =
conditional knockout. Data were
excluded from one female
Erbb4 WT mouse with ex-
tremely high scores near the end
of the test (i.e., 5,225 cm at the
55 min time point)
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on the first day of rotarod training [post-hoc test following
significant main effect of genotype, F(1,20)=5.95, p=
0.0242]. As shown in Table 1, significant group differences
were no longer observed by trial 5.
Hyperactivity has been reported in Nrg1+/− and Erbb4+/−
mice [4, 14, 46, 57]. In the present study, there were no
significant differences in distance traveled during a 1-hr open
field test in the Nrg1 and Erbb3 mutants (Fig. 1). A repeated
measures ANOVA indicated a significant genotype x time
interaction in the Erbb4 mice [F(11,242)=2.44, p=0.0066];
however, post-hoc tests failed to reveal significant group
differences at any one time point.
Social approach test
Sociability Significant effects of the Nrg1 genotype were
found in the test for sociability in both cohort groups
(Fig. 2). In each set of mice, the Nrg1+/− group spent
significantly more time in the side containing the
unfamiliar stranger, in comparison to the wild-type mice
[post-hoc test following significant genotype x side
interaction in cohort 1, F(1,16)=5.3, p=0.0352, and
cohort 2, F(1,28)=5.82, p=0.0226; and main effect of
genotype in cohort 2, F(1,28)=7.6, p=0.0102]. A similar
pattern was found with the Erbb3 mutants, who spent
more time in the side with the stranger mouse, and less
time in the empty cage side, than the wild-type mice [post-
hoc tests following a significant genotype x side interac-
tion [F(1,20)=9.29, p=0.0064]. Repeated measures
ANOVAs did not indicate any significant effects of
genotype in the Erbb4 groups.
Within-genotype analyses were used to determine
whether the experimental groups had significant preference
for the side containing the stranger mouse, versus the empty
cage side, in the test for sociability. In both Nrg1 cohorts,
the mutant mice spent significantly more time in the side
with the unfamiliar stranger [cohort 1, F(1,8)=11.32, p=
0.0099; cohort 2, F(1,13)=29.68, p=0.0001]. Significant
sociability was also observed in the Erbb3 mutant mice [F
(1,11)=36.92, p<0.0001] and in the Erbb4 mutant mice [F
(1,13)=14.34, p=0.0023]. However, only one of the wild-
type control groups, the Nrg1+/+ mice from the second
cohort, showed preference for the stranger mouse side [F
(1,15)=12.69, p=0.0028].
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There were no differences in number of entries during the
sociability test between wild-type and any of the respective
mutant groups (Fig. 3).
Social novelty Repeated measures ANOVAs did not reveal
any significant effects of genotype in the preference for
social novelty test, although the genotype x side interaction
approached significance in the Erbb3 group [F(1,20)=4.24,
p=0.0527]. However, all of the mouse lines had the same
pattern of results: none of the mutant groups demonstrated
social novelty preference (Fig. 4). Only the wild-type
controls had a significant preference for the newly-
introduced unfamiliar mouse (stranger 2), versus the
already-investigated stranger 1. Within-genotype ANOVAs
indicated that, in both cohort groups, only the Nrg1+/+
mice had significant social novelty preference [cohort 1, F
(1,8)=12.45, p=0.0078; cohort 2, F(1,15)=15.64, p=
0.0013]. Significant preference for the side containing the
second stranger mouse was also only observed in the Erbb3
wild-type [F(1,9)=6.19, p=0.0346] and the Erbb4 wild-
type [F(1,10)=6.0, p=0.0343] mice. Preference for the
more-novel stranger 2 mouse approached significance in
the Erbb4 mutant group [F(1,13)=3.98, p=0.0674].
As in the test for sociability, there were no significant
effects of genotype on the measure for entries in the social
novelty test (data not shown).
Ultrasonic vocalization
No differences were found in the frequency of ultrasonic
vocalization by Nrg1+/+ or +/− mouse pups during the
neonatal period (Fig. 5). Similarly, the average duration of
ultrasonic cries did not differ between the groups (data not
shown).
Discussion
The present study confirms that NRG1-ERBB signaling
plays a role in mouse social behavior. Two separate cohort
groups of male Nrg1+/− mice showed significantly en-
hanced sociability and a lack of preference for social
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novelty in the three-chambered choice task. A strikingly
similar pattern was observed in male mice with deletion of
Erbb3 in the CNS. A milder phenotype was apparent in the
Erbb4 mutant group, which included both males and
females. The changes in social behavior could not be
attributed to general hyperactivity, motor deficits, or altered
anxiety-like behavior in the mutant lines.
Genetic analysis in human linkage and association
studies has implicated alleles of NRG1 and ERBB4 with
increased risk for schizophrenia [33, 43, 45, 57, 58],
possibly through gain-of-function mutations (see review
[24]). Disease pathology has been associated with an
intrinsic state of NMDAR hypofunction [6, 23, 27, 37,
49]. Hahn et al. [17] have suggested that over-active
NRG1-ERBB4 signaling could be an underlying mecha-
nism for reduced function of NMDA receptors in schizo-
phrenia. In line with this model, NRG1 activation of
ERBB4 receptors was found to be significantly enhanced
in postmortem tissue from the dorsolateral prefrontal cortex
(PFC) of schizophrenia patients. The PFC tissue from the
patients also had higher levels of ERBB4 coupling to the
NR1 NMDAR subunit, thus providing a link for enhanced
NRG1 modulation of NMDAR function. Importantly, the
application of NRG1 could suppress NMDAR activation in
control and patient brain slices, and this effect was greater
in the schizophrenia group [17]. A similar link between
increased NRG1-ERBB signaling and decreased NMDAR
function in PFC has been demonstrated in a rat model [16].
Disruption of normal NMDA neurotransmission can lead
to deficits in social behavior, which may be relevant to
social impairment and asociality observed in schizophrenia
[3, 10, 53, 54]. Decreased social preference has been
observed in two mouse models of intrinsic NMDA
hypofunction relevant to schizophrenia. Grin1neo/neo mice,
which have reduced levels of the NR1 NMDA receptor
subunit, show abnormalities in several tests for social
behavior, including marked loss of sociability in a choice
task [9, 38]. A similar lack of sociability has recently been
reported for mice with decreased NMDA receptor glycine
affinity (Grin1D481N mice; [30]). The increased sociability
found in the present studies is in line with an opposing
effect of decreased, versus increased, NRG1 activity on
behavior mediated by NMDA receptors. Thus, if increased
NRG1-ERBB signaling leads to reduced NMDA receptor
0
100
200
300
400
500
600 Stranger 1 side
Stranger 2 side
a)
Ti
m
e 
in
 s
id
e 
(se
c)
Nrg1: Cohort 1
Nrg1+/+ Nrg1+/-
100
200
300
400
500
600
b) Nrg1: Cohort 2
Nrg1+/+ Nrg1+/-
0
100
200
300
400
500
600
c)
Ti
m
e 
in
 s
id
e 
(se
c)
Erbb3
Erbb3 WT Erbb3 cKO
0
100
200
300
400
500
600
d) Erbb4
Erbb4 WT Erbb4 cKO
Fig. 4 Time spent in each of the
side chambers during the test for
social novelty preference. None
of the mutant mouse lines had
significant preference for spend-
ing more time in the side with the
more-novel stranger 2, versus the
already-investigated stranger 1.
Data shown are mean + SEM for
each group for a 10-min test.
WT = wild-type, cKO = condi-
tional knockout. * p<0.05,
within-group comparison
between stranger 1 side and
stranger 2 side
J Neurodevelop Disord (2009) 1:302–312 309
function and deficits in social approach, then disrupted
signaling could actually enhance NMDA receptor function,
and subsequently increase sociability.
O’Tuathaigh et al. [46] examined performance of Nrg1+/−
mice in the three-chambered choice task. Unlike the present
study, the researchers reported no changes in sociability in
the mutant mice; both the wild-type and the heterozygous
groups had significant preference for the side of the chamber
containing the stranger mouse. One reason for the discrepant
results could be the background strain used for the mutant
mice. O’Tuathaigh et al. [46] tested Nrg1+/− mice on a
C57BL/6 background. Inbred strain distributions for social
preference have shown that the C57BL/6J inbred strain has
significant sociability in the choice task [41, 42]. The high
levels of sociability in the wild-type groups of the
O’Tuathaigh et al. [46] report may have made detection of
further increases in the Nrg1+/− mice difficult. In contrast,
three of the wild-type groups in the present study did not
show preference for spending more time in proximity to the
stranger mouse than to the empty wire cage. It is notable that
several inbred mouse strains are characterized by a similar
low sociability in the choice task [41, 42].
We found a lack of social novelty preference in both
Nrg1+/− cohort groups, and in the Erbb3 and Erbb4
conditional null mice. O’Tuathaigh et al. [46] reported a
similar failure to prefer the newly-introduced stranger 2
mouse to the already-investigated stranger 1 in Nrg1+/−
mice (both male and female). Since social novelty
preference is dependent upon the ability of the subject
mouse to discriminate between the two social partners, one
explanation for the findings is that disruption of NRG1-
ERBB signaling leads to specific deficits in social recogni-
tion. In our study and the O’Tuathaigh [46] study, Nrg1+/−
mice were not impaired in a buried food test for olfactory
ability, indicating that anosmia in the mutants was not the
underlying reason for the lack of social novelty preference.
Interestingly, Grin1D481N mice had persistent deficits in
sociability in the three-chambered choice task, but highly
significant preference for stranger 2, providing evidence
that reduced NMDAR function does not disrupt social
novelty preference [30]. Preliminary evidence from our
laboratory suggests that mice with interneuron-specific
deletion of Erbb4 in CNS (Erbb4lox/-Dlx-Cre) also have
deficient preference for social novelty.
Hyperactivity in various experimental settings has been
reported for several Nrg1+/− mouse lines [4, 14, 46, 47,
57]. One interpretation for these findings is that disruption of
NRG1-ERBB signaling leads to behavioral disinhibition.
Thus, increased sociability may be one facet of a general
tendency for impulsive behavior in novel environments.
However, the Nrg1+/− mice in the present study did not
have higher levels of exploration or activity in either the
elevated plus maze or open field tests, indicating that the
increased sociability may reflect selective, inappropriate
social approach. It is notable that the mutant Nrg1 and
Erbb4 lines characterized by hyperactivity were either on a
C57BL/6 [4, 46, 47, 57] or a C57BL/6 × 127/SVEV [14]
background. Differential effects of targeted gene disruption,
dependent upon background strain, have been reported for
other mouse models of neuropsychiatric disorders [8, 20, 40].
In addition to regulation of NMDA receptor function,
NRG1 has effects on multiple other neurotransmitter
systems [29, 34, 48, 52]. A recent study found that
Nrg1+/− mice have general increases of the serotonin
transporter in forebrain [7]. We have found that mutant
mice with targeted deletion of Slc6a4, the serotonin
transporter gene, have a lack of sociability and intact
preference for social novelty [40]. Other researchers have
reported that Slc6a4-null mice have significant decreases in
social interaction and aggression, and are hypoactive across
various experimental settings [21, 25, 26]. These findings
suggest that the pattern of change observed in the Nrg1+/−
mice is in line with opposing behavioral effects of
increased, versus decreased, function of the serotonin
transporter, as well as NMDAR function.
Overall, our results provide confirmation that NRG1-
ERBB signaling plays a significant role in social behavior,
which could have implications for neurodevelopmental
disorders characterized by social deficits, including schizo-
phrenia, autism, fragile X syndrome, and Smith-Lemli-
Opitz syndrome. The increased sociability observed in the
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present study may reflect dysregulation of NRG1-mediated
NMDAR activity. Functional characterization of Nrg1-
overexpressing mice could provide additional evidence of
alterations in social approach, as well as other behavioral
domains relevant to schizophrenia, mediated by NRG1-
ERBB signaling.
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